Biocon Limited Biocon Limited

Biocon Limited

BIOCON

Rankning i aktier #3387
Biocon Limited functions as a biopharmaceutical firm, engaged in the production... Biocon Limited functions as a biopharmaceutical firm, engaged in the production of pharmaceutical, medicinal chemical, and plant-derived products. Its business activities are organized into distinct segments: Generics, Novel Biologics, Biosimilars, and Research Services. The company dedicates its efforts to crucial therapeutic domains, including diabetes, oncology, immunology, ophthalmology, and bone health disorders. Furthermore, Biocon provides comprehensive services encompassing the discovery, development, and manufacturing of both small and large molecules. With a wide international presence, it caters to customers in roughly 120 nations. Headquartered in Bengaluru, India, Biocon Limited commenced operations in 1978.
Aktiekurs
$3.76
Marknadsvärde
$5.14B
Förändring (1 dag)
-2.11%
Förändring (1 år)
-7.08%
Land
IN
Handel Biocon Limited (BIOCON)

Kategori

Healthcare
EPS för Biocon Limited (BIOCON)
EPS per June 2026 TTM: $0.04
Enligt Biocon Limiteds senaste finansiella rapporter och aktiekurs är bolagets nuvarande EPS (TTM) $0.04. Vid slutet av 2024 hade bolaget ett EPS på $0.10, en ökning jämfört med EPS från 2023 som var $0.05.
EPS-historik för Biocon Limited från 2004 till 2026
EPS vid slutet av varje år
År EPS Ändra
2026 (TTM) $0.04 -62.50%
2025 $0.10 -3.51%
2024 $0.10 117.16%
2023 $0.05 -34.17%
2022 $0.07 -15.85%
2021 $0.09 1.55%
2020 $0.08 -23.87%
2019 $0.11 127.22%
2018 $0.05 -39.53%
2017 $0.08 13.76%
2016 $0.07 6.33%
2015 $0.07 12.95%
2014 $0.06 -26.35%
2013 $0.08 40.32%
2012 $0.06 -19.09%
2011 $0.07 25.58%
2010 $0.06 249.38%
2009 $0.02 -84.00%
2008 $0.10 142.13%
2007 $0.04 21.11%
2006 $0.03 -14.32%
2005 $0.04 27.16%
2004 $0.03 0.00%
EPS för liknande företag eller konkurrenter
Företag EPS EPS-differens Land
$17.32 46,086.67%
US
$-7.98 -21,380.00%
US
$-5.29 -14,206.67%
AU
- -
CH
$27.74 73,873.33%
NL